Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice
Among the vinca-alkaloid class, vincristine is a potent chemotherapeutic agent with significant neurotoxic effects and is employed to address a wide spectrum of cancer types. Recently, the therapeutic potential of the cholecystokinin type 2 receptor (CCK2R) as a target for vincristine-induced periph...
Saved in:
Main Authors: | Amandine Bernard (Author), Mohamad Mroué (Author), Sylvie Bourthoumieu (Author), Malcolm Boyce (Author), Laurence Richard (Author), Franck Sturtz (Author), Claire Demiot (Author), Aurore Danigo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice
by: Amandine Bernard, et al.
Published: (2022) -
The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management
by: Amandine Bernard, et al.
Published: (2021) -
Neuroprotective Effect of Polyvalent Immunoglobulins on Mouse Models of Chemotherapy-Induced Peripheral Neuropathy
by: Mohamad Mroué, et al.
Published: (2024) -
Neuroprotective Effect of Ramipril Is Mediated by AT2 in a Mouse MODEL of Paclitaxel-Induced Peripheral Neuropathy
by: Hichem Bouchenaki, et al.
Published: (2022) -
The Angiotensin II Type 2 Receptor, a Target for Protection and Regeneration of the Peripheral Nervous System?
by: Aurore Danigo, et al.
Published: (2021)